Cambrex expands process research and development capabilities

Cambrex Corporation, a specialist manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), announced an investment to expand chemical and analytical development capabilities at its Charles City, Iowa plant

picture of

Breaking News

PCI welcomes UK Government to its US Center of Excellence

Official Trade Mission aims to build further on strong investment and trade relations between US and Wales

CPIís National Formulation Centre set to open

The Centre for Process Innovation, the UKís technology innovation provider for process manufacturing, announced that ...

Idifarma makes serialisation investment

Spanish contract development and manufacturing organisation (CDMO) Idifarma has announced its plans to meet forthcoming ...

Transform and grow: manufacturing excellence in specialty chemicals

With access to diverse end markets such as construction, automotive, electronics and agriculture, the ubiquitous ...

Cobra Biologics and Symbiosis awarded £1.9 m Innovate UK Grant

Funding will be used to develop world-leading capabilities in drug substance and drug product viral vector production ...

Porton Pharma Solutions and BioDuro announce strategic alliance

Porton Pharma Solutions,†a leading provider of custom, cross lifecycle active pharmaceutical ingredient (API) ...

Serialisation: one year and counting

The Falsified Medicines Directive (FMD) introduces pan-European measures to prevent counterfeit medicines from entering ...

Hospital-owned generics initiative unlikely to benefit the CMO industry

A recently-announced plan to establish a not-for-profit generic pharmaceutical company is unlikely to be a boon to the ...

Clover Biopharmaceuticals selects GEís biomanufacturing platform

The new facility will support a robust pipeline of biopharmaceuticals, including a biosimilar to Enbrel‚ for the ...

The contract services and outsourcing industry: a small molecule CDMO perspective

The pharmaceutical outsourcing industry has seen major growth during the past decade; but, with an ever-changing ...

Gene transfer therapy approved for the treatment of ALL: part I

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

Slovakia: the pharmaceutical marketís best kept secret?

Pharmaceutical manufacturing in Europe

Opening of contract manufacturing provider Biovation Labs

Biovation Labs has been developed from the ground up to provide companies with a partner to handle product m ...

PCI Clinical Services gets green light to begin operations in expanded site

International pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has completed validation and ...